Healthy adult woman
Conditions
Interventions
Chlorella food
Placebo control food
Sponsors
Sun Chlorella Corporation
Chiyoda Paramedical Care Clinic, Metabologenomics, Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1)Healty woman who are 20 or more to less than 60 years old (2)Healthy Japanese subjects who defecate three to five times per week (3) Subjects must be able to come to the designated facility on the scheduled date of the clinical test (4)Subjects who are explained about the clinical test, show understanding of the test procedures, and obtain written consent from themselves in advance
Exclusion criteria
Exclusion criteria: (1) Subjects who are continuously receiving treatment with medicines (2) Subjects who regularly takes food for specified health use, functional foods, health foods, etc. that may affect the test. (3) Subjects who are pregnant (including subjects who may be pregnant) or lactating. (4) Subjects who donate blood or collect 200 ml or more of whole blood from 4 weeks prior to the start of the clinical test. (5) Subjects who collect 400 ml or more of whole blood from 16 weeks prior to the start of the clinical test. (6) Subjects whose blood collection volume from the month 12 months prior to the start of the clinical test to the start of it, plus the total planned blood collection volume for the clinical test, exceeds 800 ml (7) Subjects currently participate as test subjects in another clinical test or have participated in the test within 4 weeks (8) Subjects with pain or bleeding during defecation (9) Subjects who underwent laparotomy within 6 months of the test (10) Subjects who took antibiotics within 6 months of the test (11) Subjects who drink too much alcohol and smoke excessively. (12) Subjects with extremely irregular eating habits, shift work or midnight shift (13) Subjects who plan to change their lifestyle substantially during the test period (14) Subjects who are chronically prone to diarrhea (15) Subjects who falls under any of the following (a) Subjects with heart, liver or kidney disease (including when it is a complication of another disease) (b) Subjects with a history of cardiovascular disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Defecation frequency | — |
Secondary
| Measure | Time frame |
|---|---|
| Fecal amount, Fecal metabolite, Intestinal flora, Clinical blood test, serum folate | — |
Countries
Japan
Contacts
Public ContactMasaki Fujishima
Sun Chlorella Corporation Production&Development Department Research&Development Group
Outcome results
None listed